NASDAQ : CATB

Catabasis Pharmaceuticals, Inc.

$8.54 USD

-$0.64 (-6.97%)

Volume
98.87K
Average Volume
528.92K
Market Capitalization
$234.86M
P/E Ratio
-5.02
Dividend Yield
0.00%
Price Target
Year High
$10.26
Year Low
$1.25
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.78
Source Headline

Get CATB Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

CATB Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

CATB Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2021-05-12 Ladenburg Thalmann Maintain Buy Buy
2021-03-11 Oppenheimer Upgrade Perform Outperform
2020-11-25 HC Wainwright & Co. Maintain Buy Buy
2020-11-02 Wedbush Downgrade Outperform Neutral
2020-10-27 Oppenheimer Downgrade Outperform Perform
2020-10-27 HC Wainwright & Co. Downgrade Buy Neutral
2020-10-01 HC Wainwright & Co. Maintain Buy Buy
2018-08-10 Citigroup Maintain Buy Buy
2018-03-20 Wedbush Maintain Outperform Outperform
2017-11-20 Citigroup Upgrade Neutral Buy
2017-10-05 Citigroup Maintain Neutral Neutral
2017-02-01 Citigroup Downgrade Buy Neutral
2016-06-09 Citigroup Maintain Buy Buy
2016-03-22 Citigroup Maintain Buy Buy
2015-07-20 Wedbush Maintain Outperform Outperform
2015-07-20 Cowen & Co. Maintain Outperform Outperform
2015-07-20 Citigroup Maintain Buy Buy
2015-07-20 Oppenheimer Maintain Outperform Outperform